Q3 2025 Seer Inc Earnings Call Transcript
Key Points
- Seer Inc (SEER) achieved a record number of third-party publications validating the Proteograph's performance across various applications.
- The company reported strong instrument shipments, with nearly three times as many instruments shipped in the first nine months of 2025 compared to all of 2024.
- Seer Inc (SEER) ended the third quarter with a strong balance sheet, holding approximately $251 million in cash, cash equivalents, and investments.
- The Proteograph ONE Assay and SP200 Automation Instrument launched in June, doubling throughput and improving precision, received overwhelmingly positive customer feedback.
- Seer Inc (SEER) has been selected for a large multi-omic study funded by the NIH, highlighting the critical role of their technology in advancing research on human health and disease.
- Seer Inc (SEER) faced challenges due to shifting government policies around tariffs and research funding, causing uncertainty and capital spending constraints on customers.
- The company experienced pressure on CapEx budgets and elongated sales cycles, particularly due to the government shutdown impacting NIH funding.
- Despite a 2% year-over-year revenue growth, the net loss for the third quarter of 2025 was $18.2 million.
- The macroeconomic environment remains challenging, with uncertainties in biopharma and academic spending due to government shutdowns and funding constraints.
- Seer Inc (SEER) anticipates full-year revenue to be in the lower half of their guidance range due to ongoing budget constraints and government funding uncertainties.
Good day, and welcome to Seer's third-quarter 2025 earnings conference call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Kelly Gura of Investor Relations. Please go ahead.
Thank you. Earlier today, Seer released financial results for the quarter ended September 30, 2025. If you have not received this news release or if you'd like to be added to the company's distribution list, please send an email to [email protected]. In addition, during today's conference call, we will be referencing a slide presentation that can be accessed on the Events and Presentations section of Seer's Investor Relations website. Joining me today from Seer are Omid Farokhzad, Chief Executive Officer and Chair of the Board; and David Horn, Chief Financial Officer and President.
Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
